You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
28 March 2022
Alliance Pharma has accessed the OTC scar treatment market in the US by acquiring the ScarAway brand and US rights to Kelo-cote from Perrigo for USD19.4 million in cash.
22 March 2022
Alliance Pharma is in talks to acquire two products in the US.
20 January 2022
Alliance Pharma is seeking further consumer healthcare deals after the acquisition of Amberen helped lift its sales by 27% at constant currencies to GBP170 million (USD227 million) in 2021.
23 July 2021
Acquiring Amberen helped lift Alliance Pharma’s sales by around a quarter in the first half of 2021. The UK-based company said it had now completed integration of the Amberen brand into its US business.
29 June 2021
Alliance Pharma has announced that Kristof Neirynck of Walgreens Boots Alliance (WBA) is joining the company as an independent non-executive director on 1 December 2021.
15 April 2021
Futura Medical has reported its annual results, and Alliance Pharma is losing a non-executive director.
21 January 2021
Alliance Pharma said its Consumer Healthcare business had “performed well given the market backdrop” in 2020, with sales up by 1%. By contrast, the UK-based company’s Prescription Medicines business reported sales down by 14% due to the COVID-19 pandemic.